EBV in Hodgkin Lymphoma
2009

The Role of Epstein-Barr Virus in Hodgkin Lymphoma

publication Evidence: high

Author Information

Author(s): Giuseppina Massini, Doerte Siemer, Stefan Hohaus

Primary Institution: Istituto di Ematologia, Università Cattolica S. Cuore, Rome, Italy

Hypothesis

What is the role of Epstein-Barr virus (EBV) in the pathogenesis of Hodgkin lymphoma (HL)?

Conclusion

EBV is significantly associated with Hodgkin lymphoma, influencing its pathogenesis and immune response.

Supporting Evidence

  • Up to 40% of Hodgkin lymphoma cases are associated with EBV.
  • EBV alters the immune response in Hodgkin lymphoma, favoring a Th1 reaction.
  • Circulating EBV-DNA may serve as a biomarker for monitoring therapy response.

Takeaway

This study explains how a virus called Epstein-Barr can cause a type of cancer called Hodgkin lymphoma, affecting how the body fights the disease.

Methodology

The review discusses various studies linking EBV to Hodgkin lymphoma, focusing on its biological and epidemiological aspects.

Limitations

The review does not cover all potential infectious agents associated with Hodgkin lymphoma.

Participant Demographics

The review mentions that EBV is more frequent in males, children, and older adults, particularly in developing countries.

Digital Object Identifier (DOI)

10.4084/MJHID.2009.013

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication